Iron oxide MR contrast agents for molecular and cellular imaging

NMR in Biomedicine

Volumn 17, Issue 7, 2004, Pages 484-499

  Bulte, Jeff W M ^a   Kraitchman, Dara L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

(Stem) cell tracking; Macrophage; MR contrast agent; Receptor imaging; Superparamagnetic iron oxide

Indexed keywords

BIOCOMPATIBILITY; CELLS; GADOLINIUM; MACROMOLECULES; MAGNETIC RESONANCE IMAGING; MOLECULAR STRUCTURE; TUMORS;

CELL MIGRATION; LIGANDS; RETICULOENDOTHELIAL SYSTEM (RES); SUPERPARAMAGNETIC IRON OXIDE (SPIO);

IRON OXIDES;

GADOLINIUM; IRON; IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ALZHEIMER DISEASE; BIOCOMPATIBILITY; BREAST CANCER; CANCER STAGING; CELL ACTIVITY; CELL CULTURE; CELL LABELING; CELL MIGRATION; CELL TRANSFER; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CYTOLOGY; DIAGNOSTIC VALUE; DRUG CLEARANCE; GLIOSARCOMA; HEART INFARCTION; HEMATOLOGIC MALIGNANCY; HUMAN; IN VIVO STUDY; LIVER CANCER; LUNG SMALL CELL CANCER; LYMPHOCYTE TRANSFER; MACROMOLECULE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; BIOPOLYMERS; CELL MOVEMENT; CELL PHYSIOLOGY; CELL SEPARATION; CONTRAST MEDIA; FERRIC COMPOUNDS; GENE EXPRESSION PROFILING; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MOLECULAR BIOLOGY; PARTICLE SIZE;

SPIO;

EID: 9244244699     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.924     Document Type: Review

References (144)

1. Herschman HR. Molecular imaging: looking at problems, seeing solutions. Science 2003; 302: 605-608.
2. Mendonca Dias MH, Lauterbur PC. Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn. Reson. Med. 1986; 3: 328-330.
3. Olsson M, Persson B, Salford L, Schroder U. Ferromagnetic particles as contrast agents in T2 NMR imaging. Magn. Reson. Imaging 1986; 4: 437-440.
4. Renshaw PF, Owen CS, McLaughlin AC, Frey TG, Leight JS Jr. Ferromagnetic contrast agents: a new approach. Magn. Reson. Med. 1986; 3: 217-225.
5. Wolf GL, Burnett KR, Goldstein EJ, Joseph PM. Magnetic Resonance Annual, Kressel H (ed.). Raven Press: New York, 1985; 231-266.
6. Meldrum FC, Heywood BR, Mann S. Magnetoferritin: in vitro synthesis of a novel magnetic protein. Science 1992; 257: 522-523.
7. Bulte JW, Douglas T, Mann S, Frankel RB, Moskowitz BM, Brooks RA, Baumgarner CD, Vymazal J, Strub W, Frank JA. Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent. J. Magn. Reson. Imaging 1994; 4: 497-505.
8. Bulte JW, Douglas T, Mann S, Vymazal J, Laughlin PG, Frank JA. Initial assessment of magnetoferritin biokinetics and proton relaxation enhancement in rats. Acad Radiol. 1995; 2: 871-878.
9. Bulte JWM, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 2001; 19: 1141-1147.
10. Strable E, Bulte JWM, Moskowitz BM, Vivekanandan K, Allen M, Douglas T. Synthesis and characterization of soluble iron oxide-dendrimer complexes. Chem. Mater 2001; 13: 2201-2209.
11. Josephson L, Groman EV, Menz E, Lewis JM, Bengele H. A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. Magn. Reson. Imag. 1990; 8: 637-646.
12. Reimer P, Weissleder R, Lee AS, Wittenberg J, Brady TJ. Receptor imaging: application to MR imaging of liver cancer. Radiology 1990; 177: 729-734.
13. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest. Radiol. 2004; 39: 56-63.
14. Schaffer BK, Linker C, Papisov M, Tsai E, Nossiff N, Shibata T, Bogdanov A Jr, Brady TJ, Weissleder R. MION-ASF: biokinetics of an MR receptor agent. Magn. Reson. Imag. 1993; 11: 411-417.
15. Dutton AH, Tokuyasu KT, Singer SJ. Iron-dextran antibody conjugates: general method for simultaneous staining of two components in high-resolution immunoelctron microscopy. Proc. Natl Acad. Sci. USA 1979; 76: 3392-3396.
16. Sanderson CJ, Wilson DV. A simple method for coupling proteins to insoluble polysaccharides. Immunology 1971; 20: 1061-1065.
17. Weissleder R, Lee AS, Fischman AJ, Reimer P, Shen T, Wilkinson R, Callahan RJ, Brady TJ. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. Radiology 1991; 181: 245-249.
18. Weissleder R, Lee AS, Khaw BA, Shen T, Brady TJ. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 1992; 182: 381-385.
19. Remsen LG, McCormick CI, Roman-Goldstein S, Nilaver G, Weissleder R, Bogdanov A, Hellstrom I, Kroll RA, Neuwelt EA. MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for non-invasive diagnosis. Am. J. Neuroradiol. 1996; 17: 411-418.
20. Bulte JWM, Verkuyl JM, Herynek V, Katsanis E, Brocke S, Holla M, Frank JA. Magnetoimmunodetection of (transfected) ICAM-1 gene expression. Proc. Int. Soc. Magn. Reson. Med. 1998; 6: 307.
21. Bulte JWM, Zhang S, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl Acad. Sci. USA 1999; 96 15256-15261.
22. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med. 2001; 7: 1241-1244.
23. Renshaw PF, Owen CS, Evans AE, Leigh JS Jr. Immunospecific NMR contrast agents. Magn. Reson. Imag. 1986; 4: 351-357.
24. Cerdan S, Lotscher HR, Kunnecke B, Seelig J. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Magn. Reson. Med. 1989; 12: 151-163.
25. Suwa T, Ozawa S, Ueda M, Ando N, Kitajima M. Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody. Int. J. Cancer 1998; 75: 626-634.
26. Artemov D, Mori N, Ravi R, Bhujwalla ZM. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res. 2003; 63: 2723-2727.
27. Bulte JW, Hoekstra Y, Kamman RL, Magin RL, de Leij L, Webb AG, Briggs RW, Go KG, Hulstaert CE, Miltenyi S, The TH. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn. Reson. Med. 1992; 25: 148-157.
28. Tiefenauer LX, Kuhne G, Andres RY. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. Bioconjug. Chem. 1993; 4: 347-352.
29. Tiefenauer LX, Tschirky A, Kuhne G, Andres RY. In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI. Magn. Reson. Imaging 1996; 14: 391-402.
30. Reimer P, Weissleder R, Shen T, Knoefel WT, Brady TJ. Pancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging. Radiology 1994; 193: 527-531.
31. Shen TT, Bogdanov A Jr, Bogdanova A, Poss K, Brady TJ, Weissleder R. Magnetically labeled secretin retains receptor affinity to pancreas acinar cells. Bioconjug. Chem. 1996; 7: 311-316.
32. Ichikawa T, Hogemann D, Saeki Y, Tyminski E, Terada K, Weissleder R, Chiocca EA, Basilion JP. MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia 2002; 4 523-530.
33. Moore A, Basilion JP, Chiocca EA, Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochim. Biophys. Acta 1998; 1402: 239-249.
34. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP. In vivo magnetic resonance imaging of transgene expression. Nat. Med. 2000; 6: 351-355.
35. Kresse M, Wagner S, Pfefferer D, Lawaczeck R, Elste V, Semmler W. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magn. Reson. Med. 1998; 40: 236-242.
36. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY, Aguinaldo G, Pappolla M, Duff K, Wisniewski T, Turnbull DH. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn. Reson. Med. 2003; 50: 293-302.
37. Chemla YR, Grossman HL, Poon Y, McDermott R, Stevens R, Alper MD, Clarke J. Ultrasensitive magnetic biosensor for homogeneous immunoassay. Proc. Natl Acad. Sci. USA 2000; 97: 14268-14272.
38. Josephson L, Perez JM, Weissleder R. Magnetic nanosensors for the detection of oligonucleotide sequences. Angew. Chem. Int. Edn 2001; 40: 3204-3206.
39. Grimm J, Perez JM, Josephson L, Weissleder R. Novel nanosensors for rapid analysis of telomerase activity. Cancer Res. 2004; 64: 639-643.
40. Perez JM, Josephson L, O'Loughlin T, Hogemann D, Weissleder R. Magnetic relaxation switches capable of sensing molecular interactions. Nat. Biotechnol. 2002; 20: 816-820.
41. Perez JM, Simeone J, Saeki Y, Josephson L, Weissleder R. Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. J. Am. Chem. Soc. 2003; 125: 10192-10193.
42. Perez JM, Simeone J, Tsourkos A, Josephson L, Weissleder R. Peroxidase substrate nanosensors for MR imaging. Nanoletters 2004; 4: 119-122.
43. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, Wittenberg J, Ferrucci JT. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168: 297-301.
44. Weissleder R. Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 1994; 193: 593-595.
45. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R. Non-invasive detection of clinically occult lymph-node metastases in prostate cancer. New Engl. J. Med. 2003; 348: 2491-2499.
46. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175: 494-498.
47. Weissleder R, Heautot JF, Schaffer BK, Nossiff N, Papisov MI, Bogdanov A Jr, Brady TJ. MR lymphography: study of a high-efficiency lymphotrophic agent. Radiology 1994; 191: 225-230.
48. Seneterre E, Weissleder R, Jaramillo D, Reimer P, Lee AS, Brady TJ, Wittenberg J. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology 1991; 179: 529-533.
49. Xu S, Jordan EK, Brocke S, Bulte JW, Quigley L, Tresser N, Ostuni JL, Yang Y, McFarland HF, Frank JA. Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: early histopathological correlation. J. Neurosci. Res. 1998; 52: 549-558.
50. 1-weighted MR images in rats with experimental autoimmune encephalomyelitis. Am. J. Neuroradiol. 1999; 20: 223-227.
51. Dousset V, Delalande C, Ballarino L, Quesson B, Seilhan D, Coussemacq M, Thiaudiere E, Brochet B, Canioni P, Caille JM. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn. Reson. Med. 1999; 41: 329-333.
52. Rausch M, Hiestand P, Baumann D, Cannet C, Rudin M. MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn. Reson. Med. 2003; 50: 309-314.
53. Kleinschnitz C, Bendszus M, Frank M, Solymosi L, Toyka KV, Stoll G. In vivo monitoring of macrophage infiltration in experimental ischemic brain lesions by magnetic resonance imaging. J. Cereb. Blood Flow Metab. 2003; 23: 1356-1361.
54. Rausch M, Baumann D, Neubacher U, Rudin M. In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed. 2002; 15: 278-283.
55. Rausch M, Sauter A, Frohlich J, Neubacher U, Radu EW, Rudin M. Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn. Reson. Med. 2001; 46: 1018-1022.
56. Hauger O, Delalande C, Trillaud H, Deminiere C, Quesson B, Kahn H, Cambar J, Combe C, Grenier N. MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome. Magn. Reson. Med. 1999; 41: 156-162.
57. Hanger O, Delalande C, Deminiere C, Fouqueray B, Ohayon C, Garcia S, Trillaud H, Combe C, Grenier N. Nephrotoxic nephritis and obstructive nephropathy: evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide-preliminary findings in a rat model. Radiology 2000; 217: 819-826.
58. Jo SK, Hu X, Kobayashi H, Lizak M, Miyaji T, Koretsky A, Star RA. Detection of inflammation following renal ischemia by magnetic resonance imaging. Kidney Int. 2003; 64: 43-51.
59. Beckmann N, Falk R, Zurbrugg S, Dawson J, Engelhardt P. Macrophage infiltration into the rat knee detected by MRI in a model of antigen-induced arthritis. Magn. Reson. Med. 2003; 49: 1047-1055.
60. Kresse M, Wagner S, Thode KLD, Semmler W. MR plaque imaging using superparamagnetic iron oxide particles. Proc Int. Soc. Magn. Reson. Med. 1998; 633.
61. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001; 103: 415-422.
62. Litovsky S, Madjid M, Zarrabi A, Casscells SW, Willerson JT, Naghavi M. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation 2003; 107: 1545-1549.
63. Schmitz SA, Taupitz M, Wagner S, Wolf KJ, Beyersdorff D, Hamm B. Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J. Magn. Reson. Imag. 2001; 14: 355-361.
64. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003; 107: 2453-2458.
65. Beckmann N, Cannet C, Fringeli-Tanner M, Baumann D, Pally C, Bruns C, Zerwes HG, Andriambeloson E, Bigaud M. Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn. Reson. Med. 2003; 49: 459-467.
66. Zhang Y, Dodd SJ, Hendrich KS, Williams M, Ho C. Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration. Kidney Int. 2000; 58: 1300-1310.
67. Kanno S, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. A novel approach with magnetic resonance imaging used for the detection of lung allograft rejection. J. Thorac. Cardiovasc. Surg. 2000; 120 923-934.
68. Kanno S, Wu YJ, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 2001; 104 934-938.
69. Ghosh P, Hawrylak N, Broadus J, Greenough WT, Lauterbur PC. NMR imaging of transplanted iron oxide-labelled cells in the rat brain. Proc. Soc. Magn. Reson. Med. 1990; 9: 1193.
70. Hawrylak N, Ghosh P, Broadus J, Schlueter C, Greenough WT, Lauterbur PC. Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp. Neurol. 1993; 121: 181-192.
71. Norman AB, Thomas SR, Pratt RG, Lu SY, Norgren RB. Magnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast agent. Brain Res. 1992; 594: 279-283.
72. Butte JWM, Ma LD, Magin RL, Kamman RL, Hulstaert CE, Go KG, The TH, de Leij L. Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn. Reson. Med. 1993; 29: 32-37.
73. Chan TW, Eley C, Liberti P, So A, Kressel HY. Magnetic resonance imaging of abscesses using lipid-coated iron oxide particles. Invest. Radiol. 1992; 27: 443-449.
74. Yeh TC, Zhang W, Ildstad ST, Ho C. Intracellular labeling of T-cells with superparamagnetic contrast agents. Magn. Reson. Med. 1993; 30: 617-625.
75. Sipe JC, Filippi M, Martino G, Furlan R, Rocca MA, Rovaris M, Bergami A, Zyroff J, Scotti G, Comi G. Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn. Reson. Imag. 1999; 17: 1521-1523.
76. Zelivyanskaya ML, Nelson JA, Poluektova L, Uberti M, Mellon M, Gendelman HE, Boska MD. Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging. J. Neurosci. Res. 2003; 73: 284-295.
77. Moore A, Weissleder R, Bogdanov A Jr. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J. Magn. Reson. Imag. 1997; 7: 1140-1145.
78. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr. Magnetically labeled cells can be detected by MR imaging. J. Magn. Reson. Imag. 1997; 7: 258-263.
79. Franklin RJ, Blaschuk KL, Bearchell MC, Prestoz LL, Setzu A, Brindle KM, ffrench-Constant C. Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. Neuroreport 1999; 10: 3961-3965.
80. van den Bos EJ, Wagner A, Mahrholdt H, Thompson RB, Morimoto Y, Sutton BS, Judd RM, Taylor DA. Improved efficacy of stem cell labeling for magnetic resonance imaging studies by the use of cationic liposomes. Cell Transplant. 2003; 12: 743-756.
81. Butte JWM, Laughlin PG, Jordan EK, Tran VA, Vymazal J, Frank JA. Tagging of T cells with superparamagnetic iron oxide: uptake kinetics and relaxometry. Acad. Radiol. 1996; 3(Suppl. 2): S301-S303.
82. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 1999; 10: 186-191.
83. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000; 18: 410-414.
84. Kaufman CL, Williams M, Ryle LM, Smith TL, Tanner M, Ho C. Superparamagnetic iron oxide particles transactivator protein-fluorescein isothiocyanate particle labeling for in vivo magnetic resonance imaging detection of cell migration: uptake and durability. Transplantation 2003; 76: 1043-1046.
85. Dodd CH, Hsu HC, Chu WJ, Yang P, Zhang HG, Mountz JD Jr, Zinn K, Forder J, Josephson L, Weissleder R, Mountz JM, Mountz JD. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. J. Immunol. Meth. 2001; 256: 89-105.
86. Zhao M, Kircher MF, Josephson L, Weissleder R. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug. Chem. 2002; 13: 840-844.
87. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY. Transferrin receptor on endothelium of brain capillaries. Nature 1984; 312: 162-163.
88. Bulte JWM, Ben-Hur T, Miller BR, Mizrachi-Kol R, Einstein O, Reinhartz E, Zywicke HA, Douglas T, Frank JA. MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain. Magn. Reson. Med. 2003; 50: 201-205.
89. Daldrup-Link HE, Rudelius M, Oostendorp RA, Settles M, Piontek G, Metz S, Rosenbrock H, Keller U, Heinzmann U, Rummeny EJ, Schlegel J, Link TM. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003; 228: 760-767.
90. Moore A, Josephson L, Bhorade R, Basilion JP, Weissleder R. Human transferrin receptor gene as a marker gene for MR imaging. Radiology 2001; 221: 244-250.
91. Berry CC, Charles S, Wells S, Dalby MJ, Curtis ASG. The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture. Int. J. Pharm. 2004; 269: 211-225.
92. Ahrens ET, Feili-Hariri M, Xu H, Genove G, Morel PA. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn. Reson. Med. 2003; 49: 1006-1013.
93. Bryant LH Jr, Bulte JWM. In Focus on Biotechnology: Physics and Chemistry Basis of Biotechnology, Vol. 7, de Cuyper M, Bulte JWM (eds). Kluwer Academic: Dordrecht, 2001.
94. Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR Jr. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc. Natl Acad. Sci. USA 1996; 93: 4897-4902.
95. Tang MX, Redemann CT, Szoka FC Jr. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug. Chem. 1996; 7: 703-714.
96. Zhang Z-Y, Smith BD. High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model. Bioconjug. Chem. 2000; 11: 805-814.
97. Bulte JWM, Douglas T, van Gelderen P, Lewis BK, Frank JA. Cellular imaging using magnetodendrimers: application to human stem cells and neoplastic cells in vivo. Proc. Int. Soc. Magn. Reson. Med. 2001; 9: 52.
98. Bulte JWM, Lu J, Zywicke H, van Gelderen P, Douglas T, McDonald JW, Frank JA. 3D MR tracking of magnetically labeled embryonic stem cells transplanted in the contusion injured rat spinal cord. Proc. Int. Soc. Magn. Reson. Med. 2001; 9: 130.
99. Hakumaki JM, Bulte JWM, Shamblott MJ, Zhang J, Douglas T, van Zijl PCM, Gearhart JD, Kerr D. Magnetic resonance imaging of murine EG-derived neural stem cells in mouse lower motor neuron paralysis. Proc. Int. Soc. Magn. Reson. Med. 2004; 12.
100. Hakumaki JM, Savitt JM, Gearhart JD, Dawson TM, Dawson VL, Bulte JWM. MRI detection of labeled neural progenitor cells in a mouse model of Parkinson's disease. Dev. Brain Res. 2001; 132: A43-A44.
101. Lee I-H, Bulte JWM, Schweinhardt P, Douglas T, Trifunovski A, Hofstetter C, Olson L, Spenger C. In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp. Neurol. 2004; 187: 509-516.
102. Walter GA, Cahill KS, Huard J, Feng H, Douglas T, Sweeney HL, Bulte JWM. Noninvasive monitoring of stem cell transfer for muscle disorders. Magn. Reson. Med. 2004; 51: 273-277.
103. Billotey C, Wilhelm C, Devaud M, Bacri JC, Bittoun J, Gazeau F. Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging. Magn. Reson. Med. 2003; 49 646-654.
104. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003; 24: 1001-1011.
105. Wilhelm C, Gazeau F, Roger J, Pons JN, Bacri JC. Interaction of anionic superparamagnetic nanoparticles with cells: kinetic analysis of mebrane adsorption and subsequent internalization. Langmuir 2002; 18: 8148-8155.
106. Wilhelm C, Cebers A, Bacri JC, Gazeau F. Deformation of intracellular endosomes under a magnetic field. Eur. Biophys. J. 2003; 32: 655-660.
107. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH Jr, Bulte JW. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228: 480-487.
108. Frank JA, Zywicke H, Jordan EK, Mitchell J, Lewis BK, Miller B, Bryant LH Jr, Bulte JWM. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad. Radiol. 2002; 9(Suppl. 2): S484-S487.
109. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, Schwindt W, Buhrle C. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl Acad. Sci. USA 2002; 99 16267-16272.
110. Kalish H, Arbab AS, Miller BR, Lewis BK, Zywicke HA, Bulte JWM, Bryant LH Jr, Frank JA. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn. Reson. Med. 2003; 50: 275-282.
111. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland HF, Frank JA. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann. Neurol. 2004; 55 654-659.
112. Cahill KS, Silver X, Gaidosh G, Byrne BJ, Walter GA. Non-invasive monitoring and tracking of muscle stem cells. Proc. Int. Soc. Magn. Reson. Med. 2003; 11: 368.
113. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JWM. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003; 107: 2290-2293.
114. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agents for cellular imaging. Radiology 2003; 229 838-846.
115. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JWM. Feridex labelling of mesenchymal stem cells inhibits chondrogenisis but not adipogenisis or osteogenesis. NMR in Biomed 2004; 17: 513-517.
116. Zhang RL, Zhang L, Zhang ZG, Morris D, Jiang Q, Wang L, Zhang LJ, Chopp M. Migration and differentiation of adult rat subventricular zone progenitor cells transplanted into the adult rat striatum. Neuroscience 2003; 116: 373-382.
117. Zhang ZG, Jiang Q, Zhang R, Zhang L, Wang L, Arniego P, Ho KL, Chopp M. Magnetic resonance imaging and neurosphere therapy of stroke in rat. Ann. Neurol. 2003; 53: 259-263.
118. Dick AJ, Guttman MA, Raman VK, Peters DC, Hill JM, Pessanha BS, Scott G, Smith S, McVeigh ER, Lederman RJ. Real-time MRI enables targeted injection of labeled stem cells to the border of recent porcine myocardial infarction based on functional and tissue characteristics. Proc. Int. Soc. Magn. Reson. Med. 2003; 11: 365.
119. Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, Pessanha BS, Guttman MA, Varney TR, Martin BJ, Dunbar CE, McVeigh ER, Lederman RJ. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003; 108: 1009-1014.
120. Sorger JM, Despres D, Schimel D, McVeigh ER, Hill JM. MRI tracking of stem cell homing to myocardial infarction. Proc. Int. Soc. Magn. Reson. Med. 2003; 11: 364.
121. Hinds KA, Hill JM, Shapiro EM, Laukkanen MO, Silva AC, Combs CA, Varney TR, Balaban RS, Koretsky AP, Dunbar CE. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003; 102: 867-872.
122. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. MRI detection of single particles for cellular imaging. Proc. Natl. Acad. Sci. USA 2004; 101: 10901-10906.
123. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys. J. 1999; 76: 103-109.
124. Majors PD, Ackerman EJ, Wind RA, Douglas T, Bulte JWM. MR microscopy of magnetodendrimer uptake in single cells. Proc. Int. Soc. Magn. Reson. Med. 2002; 10: 2571.
125. Foster-Gareau P, Heyn C, Alejski A, Rutt BK. Imaging single mammalian cells with a 1.5T clinical MRI scanner. Magn. Reson. Med. 2003; 49: 968-971.
126. Heyn C, Bowen CV, Rutt BK, Gareau PJ. Single cell detection with FIESTA: effect of iron loading and distribution. Proc. Int. Soc. Magn. Reson. Med. 2003; 11: 805.
127. Turnbull DH, Wadghiri YZ, Josephson L, Wichterle H. In vivo MR micro-imaging of neuronal migration in the mouse brain. Proc. Int. Soc. Magn. Reson. Med. 2001; 9: 359.
128. Ben-Hur T, Einstein O, Mizrachi-Kol R, Ben-Menachem O, Reinhartz E, Karussis D, Abramsky O. Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia 2003; 41: 73-80.
129. Ben-Hur T, van Heeswijk R, Einstein O, Xue R, Frost E, Mori S, Reubinoff BE, Bulte JWM. In vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice: relation between cell migration and inflammation. Proc. Int. Soc. Magn. Reson. Med. 2004; 12: 159.
130. Savitt JM, Bulte JWM, Dawson VL, Gearhart JD, Shamblott MJ, Hakumaki JM, Axelman J, Dawson TM. Transplantation of differentiated human embryonic germ cells rescues apomorphine-induced rotation in a mouse model of Parkinson's disease. Movement Disord. 2002; 17 Suppl.): 694-695.
131. Jendelova P, Herynek V, deCroos J, Glogarova K, Andersson B, Hajek M, Sykova E. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn. Reson. Med. 2003; 50: 767-776.
132. Kraitchman DL, Karmarkar P, Amado LC, Atalar E, Hofmann LV, Heldman AW, Martin BJ, Pittenger MF, Bulte JWM. In vivo MR delivery and tracking of mesenchymal stem cells in myocardial infraction. Proc. Int. Soc. Magn. Reson. Med. 2003; 11: 360.
133. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
134. Karmarkar PV, Kraitchman DL, Izbudak I, Hofmann LV, Amado LC, Fritzges D, Young R, Pittenger MF, Bulte JWM, Atalar E. MR trackable intramyocardial injection catheter. Magn. Reson. Med. 2004; 51 1163-1172.
135. Lederman RJ, Guttman MA, Peters DC, Thompson RB, Sorger JM, Dick AJ, Raman VK, McVeigh ER. Catheter-based endomyocardial injection with real-time magnetic resonance imaging. Circulation 2002; 105 1282-1284.
136. Bos C, Delmas Y, Desmouliere A, Solanilla A, Hauger O, Grosset C, Dubus I, Ivanovic Z, Rosenbaum J, Charbord P, Combe C, Bulte JWM, Moonen C, Ripoche J, Gremer N. In vivo MR imaging of intravascularly-injected Endorem-labeled mesenchymal stem cells in kidney and liver. Radiology (in press).
137. Yeh TC, Zhang W, Ildstad ST, Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnefic iron-oxide particles. Magn. Reson. Med. 1995; 33: 200-208.
138. Schoepf U, Marecos EM, Melder RJ, Jain RK, Weissleder R. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 1998; 24: 642-646, 648-651.
139. Beuf O, Janier M, Asport C, Thivolet C, Billotey C. Magnetic labeled T cells in vivo tracking using MRI. Proc. Int. Soc. Magn. Reson. Med. 2003; 11: 828.
140. Moore A, Sun PZ, Cory D, Hogemann D, Weissleder R, Lipes MA. MRI of insulitis in autoimmune diabetes. Magn. Reson. Med. 2002; 47: 751-758.
141. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 2003; 63: 6838-6846.
142. 2-weighted intracellular contrast agent. Proc. Int. Soc. Magn. Reson. Med. 2004; 12: 1705.
143. Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine HA, Frank JA. Non invasive MR imaging of magnetically labelled stem cells to directly identify neovasculature in a glioma model Blood 2004; 104: (In press).
144. Coristine A, Foster P, Deoni SCL, Heyn C, Rutt BK. Positive contrast labelling of SPIO loaded cells in cell samples and spinal cord injury. Proc. Int. Soc. Magn. Reson. Med. 2004; 12: 163.